Search

Your search keyword '"Parekh, Samir"' showing total 86 results
Start Over Author "Parekh, Samir" Publisher american association for cancer research (aacr)
86 results on '"Parekh, Samir"'

1. Supplementary Data: Patient Level Data from IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Author

Lancman, Guido, primary, Parsa, Kian, primary, Kotlarz, Krzysztof, primary, Avery, Lisa, primary, Lurie, Alaina, primary, Lieberman-Cribbin, Alex, primary, Cho, Hearn Jay, primary, Parekh, Samir S., primary, Richard, Shambavi, primary, Richter, Joshua, primary, Rodriguez, Cesar, primary, Rossi, Adriana, primary, Sanchez, Larysa J., primary, Thibaud, Santiago, primary, Jagannath, Sundar, primary, and Chari, Ajai, primary

Published
2023
Full Text
View/download PDF

2. Supplementary Tables S1, S2, S3 from IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Author

Lancman, Guido, primary, Parsa, Kian, primary, Kotlarz, Krzysztof, primary, Avery, Lisa, primary, Lurie, Alaina, primary, Lieberman-Cribbin, Alex, primary, Cho, Hearn Jay, primary, Parekh, Samir S., primary, Richard, Shambavi, primary, Richter, Joshua, primary, Rodriguez, Cesar, primary, Rossi, Adriana, primary, Sanchez, Larysa J., primary, Thibaud, Santiago, primary, Jagannath, Sundar, primary, and Chari, Ajai, primary

Published
2023
Full Text
View/download PDF

3. Supplementary Data: Patient Level Data from IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Author

Lancman, Guido, primary, Parsa, Kian, primary, Kotlarz, Krzysztof, primary, Avery, Lisa, primary, Lurie, Alaina, primary, Lieberman-Cribbin, Alex, primary, Cho, Hearn Jay, primary, Parekh, Samir S., primary, Richard, Shambavi, primary, Richter, Joshua, primary, Rodriguez, Cesar, primary, Rossi, Adriana, primary, Sanchez, Larysa J., primary, Thibaud, Santiago, primary, Jagannath, Sundar, primary, and Chari, Ajai, primary

Published
2023
Full Text
View/download PDF

4. Figure S3 from IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Author

Lancman, Guido, primary, Parsa, Kian, primary, Kotlarz, Krzysztof, primary, Avery, Lisa, primary, Lurie, Alaina, primary, Lieberman-Cribbin, Alex, primary, Cho, Hearn Jay, primary, Parekh, Samir S., primary, Richard, Shambavi, primary, Richter, Joshua, primary, Rodriguez, Cesar, primary, Rossi, Adriana, primary, Sanchez, Larysa J., primary, Thibaud, Santiago, primary, Jagannath, Sundar, primary, and Chari, Ajai, primary

Published
2023
Full Text
View/download PDF

5. Figure S3 from IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Author

Lancman, Guido, primary, Parsa, Kian, primary, Kotlarz, Krzysztof, primary, Avery, Lisa, primary, Lurie, Alaina, primary, Lieberman-Cribbin, Alex, primary, Cho, Hearn Jay, primary, Parekh, Samir S., primary, Richard, Shambavi, primary, Richter, Joshua, primary, Rodriguez, Cesar, primary, Rossi, Adriana, primary, Sanchez, Larysa J., primary, Thibaud, Santiago, primary, Jagannath, Sundar, primary, and Chari, Ajai, primary

Published
2023
Full Text
View/download PDF

6. Figure S2 from IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Author

Lancman, Guido, primary, Parsa, Kian, primary, Kotlarz, Krzysztof, primary, Avery, Lisa, primary, Lurie, Alaina, primary, Lieberman-Cribbin, Alex, primary, Cho, Hearn Jay, primary, Parekh, Samir S., primary, Richard, Shambavi, primary, Richter, Joshua, primary, Rodriguez, Cesar, primary, Rossi, Adriana, primary, Sanchez, Larysa J., primary, Thibaud, Santiago, primary, Jagannath, Sundar, primary, and Chari, Ajai, primary

Published
2023
Full Text
View/download PDF

7. Data from IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Author

Lancman, Guido, primary, Parsa, Kian, primary, Kotlarz, Krzysztof, primary, Avery, Lisa, primary, Lurie, Alaina, primary, Lieberman-Cribbin, Alex, primary, Cho, Hearn Jay, primary, Parekh, Samir S., primary, Richard, Shambavi, primary, Richter, Joshua, primary, Rodriguez, Cesar, primary, Rossi, Adriana, primary, Sanchez, Larysa J., primary, Thibaud, Santiago, primary, Jagannath, Sundar, primary, and Chari, Ajai, primary

Published
2023
Full Text
View/download PDF

8. Supplementary Tables S1, S2, S3 from IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Author

Lancman, Guido, primary, Parsa, Kian, primary, Kotlarz, Krzysztof, primary, Avery, Lisa, primary, Lurie, Alaina, primary, Lieberman-Cribbin, Alex, primary, Cho, Hearn Jay, primary, Parekh, Samir S., primary, Richard, Shambavi, primary, Richter, Joshua, primary, Rodriguez, Cesar, primary, Rossi, Adriana, primary, Sanchez, Larysa J., primary, Thibaud, Santiago, primary, Jagannath, Sundar, primary, and Chari, Ajai, primary

Published
2023
Full Text
View/download PDF

9. Figure S4 from IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Author

Lancman, Guido, primary, Parsa, Kian, primary, Kotlarz, Krzysztof, primary, Avery, Lisa, primary, Lurie, Alaina, primary, Lieberman-Cribbin, Alex, primary, Cho, Hearn Jay, primary, Parekh, Samir S., primary, Richard, Shambavi, primary, Richter, Joshua, primary, Rodriguez, Cesar, primary, Rossi, Adriana, primary, Sanchez, Larysa J., primary, Thibaud, Santiago, primary, Jagannath, Sundar, primary, and Chari, Ajai, primary

Published
2023
Full Text
View/download PDF

10. Figure S2 from IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Author

Lancman, Guido, primary, Parsa, Kian, primary, Kotlarz, Krzysztof, primary, Avery, Lisa, primary, Lurie, Alaina, primary, Lieberman-Cribbin, Alex, primary, Cho, Hearn Jay, primary, Parekh, Samir S., primary, Richard, Shambavi, primary, Richter, Joshua, primary, Rodriguez, Cesar, primary, Rossi, Adriana, primary, Sanchez, Larysa J., primary, Thibaud, Santiago, primary, Jagannath, Sundar, primary, and Chari, Ajai, primary

Published
2023
Full Text
View/download PDF

11. Figure S3 from IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Author

Lancman, Guido, primary, Parsa, Kian, primary, Kotlarz, Krzysztof, primary, Avery, Lisa, primary, Lurie, Alaina, primary, Lieberman-Cribbin, Alex, primary, Cho, Hearn Jay, primary, Parekh, Samir S., primary, Richard, Shambavi, primary, Richter, Joshua, primary, Rodriguez, Cesar, primary, Rossi, Adriana, primary, Sanchez, Larysa J., primary, Thibaud, Santiago, primary, Jagannath, Sundar, primary, and Chari, Ajai, primary

Published
2023
Full Text
View/download PDF

12. Supplementary Data: Patient Level Data from IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Author

Lancman, Guido, primary, Parsa, Kian, primary, Kotlarz, Krzysztof, primary, Avery, Lisa, primary, Lurie, Alaina, primary, Lieberman-Cribbin, Alex, primary, Cho, Hearn Jay, primary, Parekh, Samir S., primary, Richard, Shambavi, primary, Richter, Joshua, primary, Rodriguez, Cesar, primary, Rossi, Adriana, primary, Sanchez, Larysa J., primary, Thibaud, Santiago, primary, Jagannath, Sundar, primary, and Chari, Ajai, primary

Published
2023
Full Text
View/download PDF

13. Supplementary Data: Patient Level Data from IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Author

Lancman, Guido, primary, Parsa, Kian, primary, Kotlarz, Krzysztof, primary, Avery, Lisa, primary, Lurie, Alaina, primary, Lieberman-Cribbin, Alex, primary, Cho, Hearn Jay, primary, Parekh, Samir S., primary, Richard, Shambavi, primary, Richter, Joshua, primary, Rodriguez, Cesar, primary, Rossi, Adriana, primary, Sanchez, Larysa J., primary, Thibaud, Santiago, primary, Jagannath, Sundar, primary, and Chari, Ajai, primary

Published
2023
Full Text
View/download PDF

14. Figure S3 from IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Author

Lancman, Guido, primary, Parsa, Kian, primary, Kotlarz, Krzysztof, primary, Avery, Lisa, primary, Lurie, Alaina, primary, Lieberman-Cribbin, Alex, primary, Cho, Hearn Jay, primary, Parekh, Samir S., primary, Richard, Shambavi, primary, Richter, Joshua, primary, Rodriguez, Cesar, primary, Rossi, Adriana, primary, Sanchez, Larysa J., primary, Thibaud, Santiago, primary, Jagannath, Sundar, primary, and Chari, Ajai, primary

Published
2023
Full Text
View/download PDF

15. Figure S5 from IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Author

Lancman, Guido, primary, Parsa, Kian, primary, Kotlarz, Krzysztof, primary, Avery, Lisa, primary, Lurie, Alaina, primary, Lieberman-Cribbin, Alex, primary, Cho, Hearn Jay, primary, Parekh, Samir S., primary, Richard, Shambavi, primary, Richter, Joshua, primary, Rodriguez, Cesar, primary, Rossi, Adriana, primary, Sanchez, Larysa J., primary, Thibaud, Santiago, primary, Jagannath, Sundar, primary, and Chari, Ajai, primary

Published
2023
Full Text
View/download PDF

16. Figure S5 from IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Author

Lancman, Guido, primary, Parsa, Kian, primary, Kotlarz, Krzysztof, primary, Avery, Lisa, primary, Lurie, Alaina, primary, Lieberman-Cribbin, Alex, primary, Cho, Hearn Jay, primary, Parekh, Samir S., primary, Richard, Shambavi, primary, Richter, Joshua, primary, Rodriguez, Cesar, primary, Rossi, Adriana, primary, Sanchez, Larysa J., primary, Thibaud, Santiago, primary, Jagannath, Sundar, primary, and Chari, Ajai, primary

Published
2023
Full Text
View/download PDF

17. Supplementary Tables S1, S2, S3 from IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Author

Lancman, Guido, primary, Parsa, Kian, primary, Kotlarz, Krzysztof, primary, Avery, Lisa, primary, Lurie, Alaina, primary, Lieberman-Cribbin, Alex, primary, Cho, Hearn Jay, primary, Parekh, Samir S., primary, Richard, Shambavi, primary, Richter, Joshua, primary, Rodriguez, Cesar, primary, Rossi, Adriana, primary, Sanchez, Larysa J., primary, Thibaud, Santiago, primary, Jagannath, Sundar, primary, and Chari, Ajai, primary

Published
2023
Full Text
View/download PDF

18. Figure S5 from IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Author

Lancman, Guido, primary, Parsa, Kian, primary, Kotlarz, Krzysztof, primary, Avery, Lisa, primary, Lurie, Alaina, primary, Lieberman-Cribbin, Alex, primary, Cho, Hearn Jay, primary, Parekh, Samir S., primary, Richard, Shambavi, primary, Richter, Joshua, primary, Rodriguez, Cesar, primary, Rossi, Adriana, primary, Sanchez, Larysa J., primary, Thibaud, Santiago, primary, Jagannath, Sundar, primary, and Chari, Ajai, primary

Published
2023
Full Text
View/download PDF

19. Figure S1 from IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Author

Lancman, Guido, primary, Parsa, Kian, primary, Kotlarz, Krzysztof, primary, Avery, Lisa, primary, Lurie, Alaina, primary, Lieberman-Cribbin, Alex, primary, Cho, Hearn Jay, primary, Parekh, Samir S., primary, Richard, Shambavi, primary, Richter, Joshua, primary, Rodriguez, Cesar, primary, Rossi, Adriana, primary, Sanchez, Larysa J., primary, Thibaud, Santiago, primary, Jagannath, Sundar, primary, and Chari, Ajai, primary

Published
2023
Full Text
View/download PDF

20. Supplementary Tables S1, S2, S3 from IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Author

Lancman, Guido, primary, Parsa, Kian, primary, Kotlarz, Krzysztof, primary, Avery, Lisa, primary, Lurie, Alaina, primary, Lieberman-Cribbin, Alex, primary, Cho, Hearn Jay, primary, Parekh, Samir S., primary, Richard, Shambavi, primary, Richter, Joshua, primary, Rodriguez, Cesar, primary, Rossi, Adriana, primary, Sanchez, Larysa J., primary, Thibaud, Santiago, primary, Jagannath, Sundar, primary, and Chari, Ajai, primary

Published
2023
Full Text
View/download PDF

21. Figure S5 from IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Author

Lancman, Guido, primary, Parsa, Kian, primary, Kotlarz, Krzysztof, primary, Avery, Lisa, primary, Lurie, Alaina, primary, Lieberman-Cribbin, Alex, primary, Cho, Hearn Jay, primary, Parekh, Samir S., primary, Richard, Shambavi, primary, Richter, Joshua, primary, Rodriguez, Cesar, primary, Rossi, Adriana, primary, Sanchez, Larysa J., primary, Thibaud, Santiago, primary, Jagannath, Sundar, primary, and Chari, Ajai, primary

Published
2023
Full Text
View/download PDF

22. Figure S4 from IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Author

Lancman, Guido, primary, Parsa, Kian, primary, Kotlarz, Krzysztof, primary, Avery, Lisa, primary, Lurie, Alaina, primary, Lieberman-Cribbin, Alex, primary, Cho, Hearn Jay, primary, Parekh, Samir S., primary, Richard, Shambavi, primary, Richter, Joshua, primary, Rodriguez, Cesar, primary, Rossi, Adriana, primary, Sanchez, Larysa J., primary, Thibaud, Santiago, primary, Jagannath, Sundar, primary, and Chari, Ajai, primary

Published
2023
Full Text
View/download PDF

23. Figure S2 from IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Author

Lancman, Guido, primary, Parsa, Kian, primary, Kotlarz, Krzysztof, primary, Avery, Lisa, primary, Lurie, Alaina, primary, Lieberman-Cribbin, Alex, primary, Cho, Hearn Jay, primary, Parekh, Samir S., primary, Richard, Shambavi, primary, Richter, Joshua, primary, Rodriguez, Cesar, primary, Rossi, Adriana, primary, Sanchez, Larysa J., primary, Thibaud, Santiago, primary, Jagannath, Sundar, primary, and Chari, Ajai, primary

Published
2023
Full Text
View/download PDF

24. Figure S2 from IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Author

Lancman, Guido, primary, Parsa, Kian, primary, Kotlarz, Krzysztof, primary, Avery, Lisa, primary, Lurie, Alaina, primary, Lieberman-Cribbin, Alex, primary, Cho, Hearn Jay, primary, Parekh, Samir S., primary, Richard, Shambavi, primary, Richter, Joshua, primary, Rodriguez, Cesar, primary, Rossi, Adriana, primary, Sanchez, Larysa J., primary, Thibaud, Santiago, primary, Jagannath, Sundar, primary, and Chari, Ajai, primary

Published
2023
Full Text
View/download PDF

25. Figure S4 from IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Author

Lancman, Guido, primary, Parsa, Kian, primary, Kotlarz, Krzysztof, primary, Avery, Lisa, primary, Lurie, Alaina, primary, Lieberman-Cribbin, Alex, primary, Cho, Hearn Jay, primary, Parekh, Samir S., primary, Richard, Shambavi, primary, Richter, Joshua, primary, Rodriguez, Cesar, primary, Rossi, Adriana, primary, Sanchez, Larysa J., primary, Thibaud, Santiago, primary, Jagannath, Sundar, primary, and Chari, Ajai, primary

Published
2023
Full Text
View/download PDF

26. Figure S1 from IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Author

Lancman, Guido, primary, Parsa, Kian, primary, Kotlarz, Krzysztof, primary, Avery, Lisa, primary, Lurie, Alaina, primary, Lieberman-Cribbin, Alex, primary, Cho, Hearn Jay, primary, Parekh, Samir S., primary, Richard, Shambavi, primary, Richter, Joshua, primary, Rodriguez, Cesar, primary, Rossi, Adriana, primary, Sanchez, Larysa J., primary, Thibaud, Santiago, primary, Jagannath, Sundar, primary, and Chari, Ajai, primary

Published
2023
Full Text
View/download PDF

27. Data from IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Author

Lancman, Guido, primary, Parsa, Kian, primary, Kotlarz, Krzysztof, primary, Avery, Lisa, primary, Lurie, Alaina, primary, Lieberman-Cribbin, Alex, primary, Cho, Hearn Jay, primary, Parekh, Samir S., primary, Richard, Shambavi, primary, Richter, Joshua, primary, Rodriguez, Cesar, primary, Rossi, Adriana, primary, Sanchez, Larysa J., primary, Thibaud, Santiago, primary, Jagannath, Sundar, primary, and Chari, Ajai, primary

Published
2023
Full Text
View/download PDF

28. Figure S4 from IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Author

Lancman, Guido, primary, Parsa, Kian, primary, Kotlarz, Krzysztof, primary, Avery, Lisa, primary, Lurie, Alaina, primary, Lieberman-Cribbin, Alex, primary, Cho, Hearn Jay, primary, Parekh, Samir S., primary, Richard, Shambavi, primary, Richter, Joshua, primary, Rodriguez, Cesar, primary, Rossi, Adriana, primary, Sanchez, Larysa J., primary, Thibaud, Santiago, primary, Jagannath, Sundar, primary, and Chari, Ajai, primary

Published
2023
Full Text
View/download PDF

29. IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Author

Lancman, Guido, primary, Parsa, Kian, additional, Kotlarz, Krzysztof, additional, Avery, Lisa, additional, Lurie, Alaina, additional, Lieberman-Cribbin, Alex, additional, Cho, Hearn Jay, additional, Parekh, Samir S., additional, Richard, Shambavi, additional, Richter, Joshua, additional, Rodriguez, Cesar, additional, Rossi, Adriana, additional, Sanchez, Larysa J., additional, Thibaud, Santiago, additional, Jagannath, Sundar, additional, and Chari, Ajai, additional

Published
2023
Full Text
View/download PDF

30. Abstract CT270: Immunogenicity of PGV_001 neoantigen vaccine in a Phase-I clinical trial, across various types of cancers in adjuvant setting

Author

Saxena, Mansi, primary, Marron, Thomas, additional, Kodysh, Julia, additional, Rubinsteyn, Alex, additional, Finnigan, John, additional, Blasquez, Ana, additional, Meseck, Marcia, additional, O'Donnell, Tim, additional, Delbeau, Daniela, additional, Galsky, Mathew, additional, Doroshow, Deborah, additional, Miles, Brett, additional, Misiukiewicz, Krzysztof, additional, Irie, Hanna, additional, Tiersten, Amy, additional, Parekh, Samir, additional, Posner, Marshall, additional, Wolf, Andrea, additional, Mandeli, John, additional, Brody, Rachel, additional, Gnjatic, Sacha, additional, Schadt, Eric, additional, Friedlander, Philip, additional, and Bhardwaj, Nina, additional

Published
2023
Full Text
View/download PDF

31. Data from A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy

Author

Upadhyay, Ranjan, primary, Boiarsky, Jonathan A., primary, Pantsulaia, Gvantsa, primary, Svensson-Arvelund, Judit, primary, Lin, Matthew J., primary, Wroblewska, Aleksandra, primary, Bhalla, Sherry, primary, Scholler, Nathalie, primary, Bot, Adrian, primary, Rossi, John M., primary, Sadek, Norah, primary, Parekh, Samir, primary, Lagana, Alessandro, primary, Baccarini, Alessia, primary, Merad, Miriam, primary, Brown, Brian D., primary, and Brody, Joshua D., primary

Published
2023
Full Text
View/download PDF

32. Data from A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy

Author

Upadhyay, Ranjan, primary, Boiarsky, Jonathan A., primary, Pantsulaia, Gvantsa, primary, Svensson-Arvelund, Judit, primary, Lin, Matthew J., primary, Wroblewska, Aleksandra, primary, Bhalla, Sherry, primary, Scholler, Nathalie, primary, Bot, Adrian, primary, Rossi, John M., primary, Sadek, Norah, primary, Parekh, Samir, primary, Lagana, Alessandro, primary, Baccarini, Alessia, primary, Merad, Miriam, primary, Brown, Brian D., primary, and Brody, Joshua D., primary

Published
2023
Full Text
View/download PDF

33. Supplementary Table S1 from A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy

Author

Upadhyay, Ranjan, primary, Boiarsky, Jonathan A., primary, Pantsulaia, Gvantsa, primary, Svensson-Arvelund, Judit, primary, Lin, Matthew J., primary, Wroblewska, Aleksandra, primary, Bhalla, Sherry, primary, Scholler, Nathalie, primary, Bot, Adrian, primary, Rossi, John M., primary, Sadek, Norah, primary, Parekh, Samir, primary, Lagana, Alessandro, primary, Baccarini, Alessia, primary, Merad, Miriam, primary, Brown, Brian D., primary, and Brody, Joshua D., primary

Published
2023
Full Text
View/download PDF

34. Supplementary Figures from A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy

Author

Upadhyay, Ranjan, primary, Boiarsky, Jonathan A., primary, Pantsulaia, Gvantsa, primary, Svensson-Arvelund, Judit, primary, Lin, Matthew J., primary, Wroblewska, Aleksandra, primary, Bhalla, Sherry, primary, Scholler, Nathalie, primary, Bot, Adrian, primary, Rossi, John M., primary, Sadek, Norah, primary, Parekh, Samir, primary, Lagana, Alessandro, primary, Baccarini, Alessia, primary, Merad, Miriam, primary, Brown, Brian D., primary, and Brody, Joshua D., primary

Published
2023
Full Text
View/download PDF

35. Supplementary Figures from A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy

Author

Upadhyay, Ranjan, primary, Boiarsky, Jonathan A., primary, Pantsulaia, Gvantsa, primary, Svensson-Arvelund, Judit, primary, Lin, Matthew J., primary, Wroblewska, Aleksandra, primary, Bhalla, Sherry, primary, Scholler, Nathalie, primary, Bot, Adrian, primary, Rossi, John M., primary, Sadek, Norah, primary, Parekh, Samir, primary, Lagana, Alessandro, primary, Baccarini, Alessia, primary, Merad, Miriam, primary, Brown, Brian D., primary, and Brody, Joshua D., primary

Published
2023
Full Text
View/download PDF

36. Supplementary Table S1 from A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy

Author

Upadhyay, Ranjan, primary, Boiarsky, Jonathan A., primary, Pantsulaia, Gvantsa, primary, Svensson-Arvelund, Judit, primary, Lin, Matthew J., primary, Wroblewska, Aleksandra, primary, Bhalla, Sherry, primary, Scholler, Nathalie, primary, Bot, Adrian, primary, Rossi, John M., primary, Sadek, Norah, primary, Parekh, Samir, primary, Lagana, Alessandro, primary, Baccarini, Alessia, primary, Merad, Miriam, primary, Brown, Brian D., primary, and Brody, Joshua D., primary

Published
2023
Full Text
View/download PDF

38. Data from Mutation-derived Neoantigen-specific T-cell Responses in Multiple Myeloma

Author

Perumal, Deepak, primary, Imai, Naoko, primary, Laganà, Alessandro, primary, Finnigan, John, primary, Melnekoff, David, primary, Leshchenko, Violetta V., primary, Solovyov, Alexander, primary, Madduri, Deepu, primary, Chari, Ajai, primary, Cho, Hearn Jay, primary, Dudley, Joel T., primary, Brody, Joshua D., primary, Jagannath, Sundar, primary, Greenbaum, Benjamin, primary, Gnjatic, Sacha, primary, Bhardwaj, Nina, primary, and Parekh, Samir, primary

Published
2023
Full Text
View/download PDF

40. Supplementary Data from SOX11 Inhibitors Are Cytotoxic in Mantle Cell Lymphoma

Author

Jatiani, Shashidhar S., primary, Christie, Stephanie, primary, Leshchenko, Violetta V., primary, Jain, Rinku, primary, Kapoor, Abhijeet, primary, Bisignano, Paola, primary, Lee, Clement, primary, Kaniskan, H. Ümit, primary, Edwards, Donna, primary, Meng, Fanye, primary, Laganà, Alessandro, primary, Youssef, Youssef, primary, Wiestner, Adrian, primary, Alinari, Lapo, primary, Jin, Jian, primary, Filizola, Marta, primary, Aggarwal, Aneel K., primary, and Parekh, Samir, primary

Published
2023
Full Text
View/download PDF

42. Data from Mutation-derived Neoantigen-specific T-cell Responses in Multiple Myeloma

Author

Perumal, Deepak, primary, Imai, Naoko, primary, Laganà, Alessandro, primary, Finnigan, John, primary, Melnekoff, David, primary, Leshchenko, Violetta V., primary, Solovyov, Alexander, primary, Madduri, Deepu, primary, Chari, Ajai, primary, Cho, Hearn Jay, primary, Dudley, Joel T., primary, Brody, Joshua D., primary, Jagannath, Sundar, primary, Greenbaum, Benjamin, primary, Gnjatic, Sacha, primary, Bhardwaj, Nina, primary, and Parekh, Samir, primary

Published
2023
Full Text
View/download PDF

48. Supplementary Data from Mutation-derived Neoantigen-specific T-cell Responses in Multiple Myeloma

Author

Perumal, Deepak, primary, Imai, Naoko, primary, Laganà, Alessandro, primary, Finnigan, John, primary, Melnekoff, David, primary, Leshchenko, Violetta V., primary, Solovyov, Alexander, primary, Madduri, Deepu, primary, Chari, Ajai, primary, Cho, Hearn Jay, primary, Dudley, Joel T., primary, Brody, Joshua D., primary, Jagannath, Sundar, primary, Greenbaum, Benjamin, primary, Gnjatic, Sacha, primary, Bhardwaj, Nina, primary, and Parekh, Samir, primary

Published
2023
Full Text
View/download PDF

50. Supplementary Data from SOX11 Inhibitors Are Cytotoxic in Mantle Cell Lymphoma

Author

Jatiani, Shashidhar S., primary, Christie, Stephanie, primary, Leshchenko, Violetta V., primary, Jain, Rinku, primary, Kapoor, Abhijeet, primary, Bisignano, Paola, primary, Lee, Clement, primary, Kaniskan, H. Ümit, primary, Edwards, Donna, primary, Meng, Fanye, primary, Laganà, Alessandro, primary, Youssef, Youssef, primary, Wiestner, Adrian, primary, Alinari, Lapo, primary, Jin, Jian, primary, Filizola, Marta, primary, Aggarwal, Aneel K., primary, and Parekh, Samir, primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results